The dPCR assay developed in this study is also easy to adopt in the clinical laboratory, and it has the potential to serve as a reliable, accurate, and cost-effective alternative to FISH and a supplementary tool to NGS gene panel results for MET amplification detection and discrimination in lung cancer patients. Here, MET is linked to lung carcinoma.